首页> 外国专利> LRK2 is inhibited by substituted pyrazolpyridan derivatives, its preparation procedure, pharmacological synthesis, pharmacological combination, and the use of the compound to prevent or treat selected cancer and neurodegenerative diseases.

LRK2 is inhibited by substituted pyrazolpyridan derivatives, its preparation procedure, pharmacological synthesis, pharmacological combination, and the use of the compound to prevent or treat selected cancer and neurodegenerative diseases.

机译:LRK2被取代的吡唑并吡喃衍生物,其制备方法,药理合成,药理组合以及该化合物用于预防或治疗某些癌症和神经退行性疾病的用途抑制。

摘要

Compound derived from pirazolopiridina replacedLRRK2 kinase inhibitor; procedure of preparation of said Compound Pharmaceutical composition, pharmaceutical use of compound; Combination; to prevent or treat a disorder selected dAnd Cancer and Neurodegenerative Diseases.
机译:吡唑并吡啶衍生物衍生的化合物取代了LRRK2激酶抑制剂;所述化合物药物组合物的制备方法,化合物的药物用途组合;预防或治疗癌症和神经退行性疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号